Combination therapy with ruxolitinib plus 5-azacytidine or continuous infusion of low dose cytarabine is feasible in patients with blast-phase myeloproliferative neoplasms.
作者信息
Mwirigi Anne, Galli Sofia, Keohane Clodagh, Raj Kavita, Radia Deepti H, Harrison Claire N, McLornan Donal P
机构信息
Guy's and St. Thomas' NHS Foundation Trust, London , UK.
出版信息
Br J Haematol. 2014 Dec;167(5):714-6. doi: 10.1111/bjh.13046. Epub 2014 Jul 22.
PMID:25048366
Abstract
摘要
Zotero 插件